Heritage Insurance (HRTG): A 4.5x P/E Stock With a Shrinking Book — Don't Chase the Rally

Heritage Insurance (HRTG) is up roughly 32% in the past four months and jumped 11.5% following its Q2 2026 earnings report. Net income hit a record $61.7 million, the combined ratio collapsed to 64.9%, and the stock trades at a trailing P/E of 4.5x. On the surface, that looks like a battered insurance stock offering a bargain entry.

But the surface is doing a lot of heavy lifting. The record quarter contains a one-time tailwind the market isn't pricing out. The book of business is shrinking. And consensus forecasts assume earnings will be cut roughly in half over the next three years. The question isn't whether Heritage can be cheap — it's whether this rally has already priced in enough optimism to make chasing it a poor risk/reward play.

The Q2 Profit Jump Needs a Reality Check

Heritage reported $61.7 million in net income for Q2 2026, up 28.5% from $48.0 million a year earlier. Diluted EPS rose 32.3% to $2.05 from $1.55. The net combined ratio (which measures underwriting profitability — premiums retained after losses and expenses as a percentage of earned premium, where anything below 100% means the underwriting itself is profitable) improved 8 percentage points to 64.9%.

These are impressive headline numbers. Here's what they don't tell you.

The $23.4 million in favorable prior-year loss development (meaning claims originally estimated for earlier years turned out to cost less than expected, flowing back to current earnings) accounts for roughly $21 million of incremental profit compared to the $2.3 million in favorable development reported in Q2 2025. That alone is about two-thirds of the $32.3 million YoY EPS increase. Without that development swing, the quarter's profit growth would have been far more modest.

Favorable prior-year development is a known variable in insurance. It can be a genuine sign of better reserving discipline, but it's also lumpy and unpredictable. You don't build a buy thesis on a quarter where one-time development accounts for most of the growth. Weather losses of $11.5 million were actually lower than Q2 2025's $12.5 million, so there's no argument that the company dodged a catastrophic event this quarter and investors should assume similar luck next time.

The Book Is Shrinking

A cheaper valuation is only attractive if the underlying business is at least stable. Heritage's top-line metrics point in the other direction.

Gross premiums written fell 5.5% to $388.4 million. Total policies-in-force declined 5.2% to 350,887. Total premiums-in-force, the snapshot of active coverage value, dropped 1.4% to $1.41 billion. Management attributes the premium decline to competitive pricing pressure in Florida commercial residential, where they've chosen to write less business at inadequate rates rather than chase volume. That's a defensible strategic call — rate adequacy before growth.

But the strategic trade-off is real. Personal lines grew, but not enough to offset the commercial residential decline. The company has started writing in Texas on a surplus lines basis, and management expects commercial premiums to level off in the second half of 2026 as growth outside Florida picks up. That's the optimistic reading. The more skeptical one is that a multi-quarter premium decline in a catastrophe-exposed P&C insurer raises the question of whether market share is being lost permanently, not just temporarily.

Revenue growth year-over-year sits at 1.5%, barely above zero. Revenue isn't the whole story in insurance — the combined ratio and book value matter more — but single-digit revenue growth alongside a shrinking book suggests this isn't a growth story in disguise.

The Valuation Gap Has a Reason

At 4.5x trailing earnings and 6.2x forward earnings, Heritage trades at a fraction of S&P 500 multiples. That's the kind of valuation disconnect that normally fires the contrarian alarm. The problem is, the market has a structural reason for pricing Heritage cheaply, not just sentiment-based fear.

Consensus projections expect earnings to decline from the current run-rate of roughly $202 million to approximately $83 million by 2029. That implies a multi-year earnings contraction of nearly 60%, even if revenue grows at a 3.1% compound annual rate. The bear case the market is pricing in isn't a weather event or a one-off catastrophe — it's the expectation that Heritage can't sustain its current earnings power as the book shrinks, reinsurance costs rise, and loss trends shift.

A 4.5x P/E doesn't automatically mean cheap. It means the market expects the earnings you see today to not persist. If consensus is right about a multi-year earnings decline, today's multiples look cheap only in hindsight.

That said, I don't think the consensus view is necessarily right. Heritage's underwriting discipline, its strengthened reinsurance program (the 2025-2026 CAT XOL program provided $2.48 billion in limit for only marginally higher cost, with $63.2 million in treaty-year expense savings from the June 2026 renewal), and CEO Ernie Garateix's focus on rate adequacy before growth are all signs of a management team that understands its competitive position. Book value per share has risen 54.5% year over year to $19.09. Annualized ROE was 45.4%.

But the gap between the current earnings profile and the consensus long-term view is the core risk. That gap isn't closing on Q2 results alone. It needs to close on premium stabilization, sustained combined ratios below 80%, and proof that outside-Florida growth can meaningfully replace lost Florida commercial volume. None of those things have happened yet.

The Rally Has Already Done the Lifting

This is where the price-action layer matters most for risk management. HRTG is up 16.7% over the past 20 days and 32% over four months. It's trading well above both its 50-day moving average ($25.93) and 200-day moving average ($26.52). The RSI sits at 65.8, not yet overbought but moving into territory where momentum buyers are doing the heavy lifting, not fundamental buyers.

The stock gapped higher on the Q2 report and has been riding that momentum into this week, where it's already pulled back roughly 7% from its recent high near $35. The 11.5% post-earnings jump means the market has arguably already priced in the optimistic scenario — record profits, cheaper reinsurance, and the expectation that the book decline is temporary.

When a stock rallies this hard on one strong quarter, the risk/reward tilts away from buyers. The setup now requires the next two quarters to confirm that the Q2 results were structural, not a one-off driven by favorable development and low weather.

So What Should an Investor Do?

Heritage Insurance isn't a falling knife anymore. The battered, sub-$25 stock that traded below book value and near 3x earnings six months ago — that was the asymmetric risk/reward setup. Today's stock, up 32% in four months and riding on a quarter where $23.4 million of favorable development inflated the headline, is a different animal.

The valuation is still cheap by traditional metrics. Return on equity is exceptional. The reinsurance program is stronger. Management is writing selectively rather than surrendering rate adequacy. These are all real positives.

But the consensus expectation of declining earnings over the next three years isn't sentiment — it's a structural bet that the shrinking book and high competitive pressure in Florida will weigh on results for longer than management expects. That bet hasn't been disproven by one quarter.

I don't think investors should chase this rally. The stock hasn't broken its technical setup — it's above both major moving averages and the RSI hasn't flashed overbought — but it also hasn't given a better entry. The patient play is to wait. Wait for a pullback toward the $26 to $28 zone near the moving averages. Wait for Q3 to show premium stabilization without relying on another round of favorable prior-year development. Wait for the Texas entry and outside-Florida growth to show they can offset the Florida commercial decline.

If those things happen, Heritage could absolutely deserve a re-rating. The moat — regional distribution, reinsurance relationships, and underwriting discipline in a high-cost environment — is intact. The problem is timing, not thesis. Don't let the cheap P/E headline push you into a position where the risk/reward is no longer attractive.

I would reassess the wait-and-see posture if HRTG breaks below $26 and shows volume-supported exhaustion, which would set up the kind of asymmetric entry this thesis actually deserves. If instead the stock continues grinding higher without premium stabilization showing up in the next report, the market may be validating the view that something is going to give between today's earnings and the consensus's 2029 forecast — and I'd prefer to find out on the sidelines than holding a position that's gone up 30% only to reverse.